Rx Medicare

The Food and Drug Administration (FDA) has approved the approval of Qutenza (capsaicin) 8% patch, a medicated skin patch that relieves the pain of post-herpetic neuralgia (PHN), a serious complication that can occur after a bout with shingles. Shingles is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox – the varicella-zoster virus.

Read More…

Related Posts

• Outpatient disc treatment gives long-term back pain relief
• Etoricoxib Provides Long Lasting Pain Relief After Surgery
• New, Targeted Pain Medicine Delivery Systems May Reduce Costs Long Term; Cost To Treat Pain Varies Significantly By Chronic Pain Condition
• FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
• Study Reveals Predictors Of Long-term Opioid Use For Back Pain
• Persistent Pain Common For Many Women 2 To 3 Years After Breast Cancer Treatment
• 100-Year-Old Woman Gets Relief From Debilitating Back Pain After Minimally Invasive Spine Surgery
• Combined Drug Treatment More Effective Than Either Alone At Reducing Neuropathic Pain
• Promising Results In Reducing Neuropathic Pain With Combined Drug Treatment, Than With Either Drug Alone
• Reducing Drug Side-Effects In Pain Relief: New Research
• Cadence Pharmaceuticals Submits Acetavance New Drug Application For The Treatment Of Acute Pain And Fever
• Suffering From Back And Neck Pain? Investing In Treatment Pays Off In The Long Run
• Fast Acting, Long Lasting Topical Relief From Arthritis Pain
• Non-drug techniques reduce pain in hospitalized patients
• Migraine With Aura: Magnetic Stimulation Is A Promising Non-Drug Treatment Option

Tags: after, approves, attacks, drug, long, pain, relief, shingles, term, treatment

This entry was posted on Thursday, November 19th, 2009 at 3:11 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.